Case Report: Maribavir for refractory cytomegalovirus viremia after renal transplantation in a child with Schimke’s immune-osseous dysplasia

Case Report: Maribavir for refractory cytomegalovirus viremia after renal transplantation in a child with Schimke’s immune-osseous dysplasia

Cytomegalovirus (CMV) is a major opportunistic pathogen in recipients of solid organ transplantation. Maribavir, a pUL97 protein kinase inhibitor, was approved for the treatment of refractory post-transplant CMV infection in the US in 2021. However, it is rarely used in pediatric patients worldwide....

Full description

Saved in:
Bibliographic Details
Main Authors: Jia-Shuan Huang, Hong-Kai Wang, Li-Ping Rong, Xiao-Yun Jiang, Long-Shan Liu, Liu-Yi Huang, Na Zhang, Zhi-Hui Yue
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Immunology
Subjects:
CMV
cytomegalovirus GCV
Schimke’s immune-osseous dysplasia
children
renal transplant
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1521763/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items